GSK: New CFO
Iain Mackay, Chief Financial Officer (CFO) at GSK, will retire in May 2023. Julie Brown, currently Chief Operating and Financial Officer at Burberry Group plc, has been selected to take on the role.
Brown has extensive experience in the biopharma and medtech sectors: having previously worked at AstraZeneca and Roche.
Julie will join GSK in April 2023 and will work with Mackay to transition responsibilities, taking responsibility as CFO and as an Executive Director of GSK on 1 May 2023.
Brown joined Burberry from Smith & Nephew where she was the Group CFO from 2013-2017. Before this, she was Interim Group CFO of AstraZeneca, having worked at the company for 25 years in finance, commercial and strategic roles.
Julie has also served as a Non-Executive Director and Audit Chair of Roche Holding AG. She is also co-Chair of the Prince’s Accounting for Sustainability Project’s CFO Leadership Network, a member of the Prime Minister’s Business Council, the Business Advisory Board to the Mayor of London and Patron of Oxford University Women in Business.
Brown is a Fellow of the Institute of Chartered Accountancy and the Institute of Tax and qualified with KPMG International Limited.